RxDoctor Payments Data

Dorothy Agbafe-Mosley, MD

Family Medicine · Wilmington, NCNPI 1881898187

Payments from drug & device makers

$6,995in general payments, 2019–2025

Across 351 payments — averaging $19.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$886
  • AstraZeneca$843
  • GSK$633
  • Lilly USA, LLC$612
  • Amgen$508
  • Esperion Therapeutics, Inc.$377
  • plus $3K from 37 others

What the payments were for

  • Food & beverage$6,960100%
  • Education$350%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,995 in reported general payments places this provider in the 90th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$36,179
Medicare patients
56
Services billed
1,680

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter54$40,949
FarxigaDapagliflozin Propanediol55$38,021
VraylarCariprazine Hcl22$29,404
LinzessLinaclotide37$22,924
JanuviaSitagliptin Phosphate23$21,669
Breztri AerosphereBudesonide/Glycopyr/Formoterol22$13,193
EliquisApixaban17$12,793
AuvelityDextromethorphan Hbr/Bupropion14$12,143
Repatha SureclickEvolocumab14$12,087
SuboxoneBuprenorphine Hcl/Naloxone Hcl14$9,713
Aimovig AutoinjectorErenumab-Aooe12$8,573
Buprenorphine Hcl174$8,176
NexlizetBempedoic Acid/Ezetimibe14$7,573
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl27$4,501
Lantus SolostarInsulin Glargine,hum.Rec.Anlog26$3,210

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$843$54,28590 claims
AbbVieVraylar, Linzess$886$52,32859 claims
GSKTrelegy Ellipta$633$40,94954 claims
MerckJanuvia$48$21,66923 claims
PfizerEliquis$318$12,79317 claims
Hikma Pharmaceuticals USABuprenorphine Hcl, Buprenorphine-Naloxone$15$12,677201 claims
Axsome Therapeutics, Inc.Auvelity$138$12,14314 claims
Indivior Inc.Suboxone$45$9,71314 claims
Esperion Therapeutics, Inc.Nexlizet$377$7,57314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Wilmington

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →